Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17029
Country/Region: South Africa
Year: 2015
Main Partner: Witkoppen Health And Welfare Centre
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: $1,386,039

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 6
CARE_CURR Age/sex: <1 Male 2016 5
CARE_CURR Age/sex: 1-4 Female 2016 37
CARE_CURR Age/sex: 1-4 Male 2016 29
CARE_CURR Age/sex: 10-14 Female 2016 48
CARE_CURR Age/sex: 10-14 Male 2016 42
CARE_CURR Age/sex: 15-19 Female 2016 54
CARE_CURR Age/sex: 15-19 Male 2016 27
CARE_CURR Age/sex: 20-24 Female 2016 253
CARE_CURR Age/sex: 20-24 Male 2016 42
CARE_CURR Age/sex: 25-49 Female 2016 3,397
CARE_CURR Age/sex: 25-49 Male 2016 1,818
CARE_CURR Age/sex: 5-9 Female 2016 54
CARE_CURR Age/sex: 5-9 Male 2016 54
CARE_CURR Age/sex: 50+ Female 2016 520
CARE_CURR Age/sex: 50+ Male 2016 297
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 145
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 130
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 4,224
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,184
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 6,683
CARE_CURR Sum of Age/Sex disaggregates 2016 6,683
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 6,683
CARE_NEW Age/sex: <1 Female 2016 8
CARE_NEW Age/sex: <1 Male 2016 11
CARE_NEW Age/sex: 1-4 Female 2016 18
CARE_NEW Age/sex: 1-4 Male 2016 15
CARE_NEW Age/sex: 10-14 Female 2016 9
CARE_NEW Age/sex: 10-14 Male 2016 9
CARE_NEW Age/sex: 15-19 Female 2016 40
CARE_NEW Age/sex: 15-19 Male 2016 14
CARE_NEW Age/sex: 20-24 Female 2016 246
CARE_NEW Age/sex: 20-24 Male 2016 35
CARE_NEW Age/sex: 25-49 Female 2016 1,392
CARE_NEW Age/sex: 25-49 Male 2016 963
CARE_NEW Age/sex: 5-9 Female 2016 8
CARE_NEW Age/sex: 5-9 Male 2016 14
CARE_NEW Age/sex: 50+ Female 2016 147
CARE_NEW Age/sex: 50+ Male 2016 100
CARE_NEW Aggregated Age/sex: <15 Female 2016 42
CARE_NEW Aggregated Age/sex: <15 Male 2016 49
CARE_NEW Aggregated Age/sex: 15+ Female 2016 1,825
CARE_NEW Aggregated Age/sex: 15+ Male 2016 1,112
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 3,029
CARE_NEW Sum of Age/sex disaggregates 2016 3,029
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,028
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 3,028
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 45
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 2,917
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 6,096
HTS_TST By Test Result: Negative 2016 32,438
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 35,626
HTS_TST Sum of Aggregated Age/Sex <15 2016 45
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 9,013
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 9,058
HTS_TST Sum of Test Result disaggregates 2016 35,626
HTS_TST_POS By Test Result: Positive 2016 3,188
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 632
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 632
PMTCT_EID Sum of Infant Age disaggregates 2016 632
TB_ART Female 2016 288
TB_ART Male 2016 168
TB_ART Sum of Sex disaggregates 2016 456
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 570
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 456
TX_CURR Age/Sex: <1 Female 2016 8
TX_CURR Age/Sex: <1 Male 2016 4
TX_CURR Age/Sex: 1-4 Female 2016 47
TX_CURR Age/Sex: 1-4 Male 2016 47
TX_CURR Age/Sex: 5-14 Female 2016 155
TX_CURR Age/Sex: 5-14 Male 2016 125
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 6,839
TX_CURR Sum of age/sex disaggregates 2016 6,839
TX_NEW By Age/Sex: <1 Female 2016 6
TX_NEW By Age/Sex: <1 Male 2016 14
TX_NEW By Age/Sex: 1-4 Female 2016 16
TX_NEW By Age/Sex: 1-4 Male 2016 8
TX_NEW By Age/Sex: 10-14 Female 2016 10
TX_NEW By Age/Sex: 10-14 Male 2016 11
TX_NEW By Age/Sex: 15-19 Female 2016 6
TX_NEW By Age/Sex: 15-19 Male 2016 29
TX_NEW By Age/Sex: 20-24 Female 2016 19
TX_NEW By Age/Sex: 20-24 Male 2016 194
TX_NEW By Age/Sex: 25-49 Female 2016 920
TX_NEW By Age/Sex: 25-49 Male 2016 1,416
TX_NEW By Age/Sex: 5-9 Female 2016 6
TX_NEW By Age/Sex: 5-9 Male 2016 16
TX_NEW By Age/Sex: 50+ Female 2016 76
TX_NEW By Age/Sex: 50+ Male 2016 122
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 2,869
TX_NEW Sum of Age/Sex disaggregates 2016 2,869
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 2,439
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 2,869